CYP2J2 overexpression ameliorates hyperlipidemia via increased fatty acid oxidation mediated by the AMPK pathway.

Abstract

OBJECTIVE:

The study aims to investigate the effect of cytochrome P450 2J2 (CYP2J2) overexpression on hyperlipidemia in mice and further to explore its effect on fatty acid oxidation in vivo and in vitro.

METHODS:

The effects and mechanisms of endothelial-specific CYP2J2 transgene (Tie2-CYP2J2-Tr) on lipid and fatty acid metabolism were investigated in high-fat diet (HFD) -treated mice. HepG2, LO2 cells, and HUVECs were exposed to 0.4 mM free fatty acid (FFA) for 24 h and used as a model to investigate the roles of CYP2J2 overexpression and epoxyeicosatrienoic acids (EETs) on fatty acid β-oxidation in vitro.

RESULTS:

Tie2-CYP2J2-Tr mice had significantly lower plasma and liver triglycerides, lower liver cholesterol and fatty acids, and reduced HFD-induced lipid accumulation. CYP2J2 overexpression resulted in activation of the hepatic and endothelial AMPKα, increased ACC phosphorylation, and increased expression of CPT-1 and PPARα, which were all reduced by HFD treatment. In FFA-treated HepG2, LO2, and HUVECs, both CYP2J2 overexpression and EETs significantly decreased lipid accumulation and increased fatty acid oxidation via activating the AMPK and PPARα pathways.

CONCLUSIONS:

Endothelial-specific CYP2J2 overexpression alleviates HFD-induced hyperlipidemia in vivo. CYP2J2 ameliorates FFA-induced dyslipidemia via increased fatty acid oxidation mediated by the AMPK and PPARα pathways.

• Authors: Shasha Zhang, Guangzhi Chen, Ning Li, Meiyan Dai, Chen Chen, Peihua Wang, Huiru Tang, Samantha L Hoopes, Darryl C Zeldin, Dao Wen Wang, Xizhen Xu
• Journal: Obesity (Silver Spring, Md.) (Obesity (Silver Spring)) Vol. 23 Issue 7 Pg. 1401-13 (Jul 2015) ISSN: 1930-739X [Electronic] United States
• PMID: 26053032 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: © 2015 The Obesity Society.

Chemical References

• 14,15-dihydroxyeicosatrienoic acid
• Fatty Acids
• Fatty Acids, Nonesterified
• Triglycerides
• Cholesterol
• AMP-Activated Protein Kinases
• 8,11,14-Eicosatrienoic Acid

Topics

• 8,11,14-Eicosatrienoic Acid (analogs & derivatives, metabolism)
• AMP-Activated Protein Kinases (metabolism)
• Animals
• Cholesterol (metabolism)
• Diet, High-Fat
• Disease Models, Animal
• Fatty Acids (metabolism)
• Fatty Acids, Nonesterified (metabolism)
• Hyperlipidemias (metabolism)
• Lipid Metabolism (drug effects)
• Liver (metabolism)
• Mice
• Mice, Inbred C57BL
• Mice, Transgenic
• Oxidative Stress (drug effects)
• Triglycerides (blood)